Search results
Author(s):
Zachary T Yoneda
,
William G Stevenson
Added:
1 year ago
Idiopathic VF
Author(s):
Marine Arnaud
,
Josselin Duchateau
,
Meleze Hocini
Added:
1 month ago
Article
VT Symposium 2026
Start date:
Oct 10, 2026
End date:
Oct 09, 2026
Event
Author(s):
Pasquale Santangeli
,
Dhanunjaya Lakkireddy
Added:
1 day ago
Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Kansas City, US) and Dr Pasquale Santangeli (Cleveland Clinic, Cleveland, OH, US) discuss evidence-based strategies for preventing complications during complex atrial fibrillation and ventricular tachycardia ablation procedures.This expert discussion focuses on safety considerations in high-risk electrophysiology procedures, comparing…
View more
Author(s):
Eiad Habib
,
Mahmoud Abdelnabi
,
Ramzi Ibrahim
,
et al
Added:
2 months ago
Author(s):
Mark T Mills
,
Peter Calvert
,
Justin Chiong
,
et al
Added:
1 year ago
Author(s):
Rohin K Reddy
,
James P Howard
,
Yousif Ahmad
,
et al
Added:
2 years ago
Author(s):
Sean DeAngelo
,
Badri Aryal
,
Maryam Haghshomar
,
et al
Added:
1 week ago
Added:
1 week ago
Source:
Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events…
View more
Author(s):
Pier D Lambiase
Added:
10 months ago
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.Interview Questions:What are the key challenges or limitations that still exist in accurately identifying VT substrates?What are the most significant recent advancements in techniques or technologies…
View more